Oculocutaneous albinism

Journal of the European Academy of Dermatology and Venereology

Volumn 17, Issue 3, 2003, Pages 251-256

  Okulicz, J F ^a   Shah, R S ^a   Schwartz, R A ^a   Janniger, C K ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Genetic disease; Oculocutaneous albinism; Pigment disorder

Indexed keywords

MELANIN; MONOPHENOL MONOOXYGENASE;

ACTINIC KERATOSIS; AMNIOCENTESIS; BASAL CELL CARCINOMA; CHEDIAK HIGASHI SYNDROME; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME ACTIVITY; HISTOPATHOLOGY; HUMAN; MELANOCYTE; MELANOGENESIS; OCULAR ALBINISM; OCULOCUTANEOUS ALBINISM; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKIN DISEASE; SKIN PIGMENTATION; SQUAMOUS CELL CARCINOMA;

ALBINISM, OCULOCUTANEOUS; HUMANS;

EID: 0038025481     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2003.00767.x     Document Type: Review

References (68)

1. Sethi R, Schwartz RA, Janniger CK. Oculocutaneous albinism. Cutis 1996; 57: 397-401.
2. Oetting WS. Albinism. Curr Opin Pediatr 1999; 11: 565-571.
3. Witkop CJ, Quevedo WC, Fitzpatrick TB. Albinism. In Scriver CR, ed. The Metabolic Basis of Inherited Disease, 6th edn. New York: McGraw-Hill, 1989: 2905-2947.
4. Stampien T, Thomas I, Schwartz RA. Cutaneous pigmentation as a sign of systemic disease. In Levine N, ed. Pigmentation and Pigmentary Disorders. Boca Raton: CRC Press, 1993: 365-394.
5. King RA, Townsend D, Oetting WS. Inherited hypopigmentary disorders. In Levine N, eds Pigmentation and Pigmentary Disorders. Boca Raton: CRC Press, 1993: 297-336.
6. Akiyama M, Shimize H, Sugiura M, Nishikawa T. Do pigmented naevi in albinism provide evidence of tyrosinase positivity? Br J Dermatol 1992; 127: 649-653.
7. Mosher DB, Fitzpatrick TB, Hori Y. Disorders of pigmentation. In Fitzpatrick TB, Eisen AZ, Wolff K, eds. Dermatology in General Internal Medicine. New York: McGraw-Hill, 1993: 903-921.
8. Spritz RA, Strunk KM, Giebel LB, King RA. Detection of mutations in the tyrosinase gene in a patient with type 1A oculocutaneous albinism. New Engl J Med 1990; 322: 1724-1728.
9. King RA, Witkop CJ. Hair-bulb tyrosinase activity in oculocutaneous albinism. Nature 1976; 263: 69-71.
10. Keeler C. Cuna Moon-child albinism, 1950-70. J Hered 1970; 61: 273-278.
11. Gershoni-Baruch R, Benderly A, Brands JM, Gilhar A. Dopa reaction test in hair bulbs of fetuses and its application to the prenatal diagnosis of albinism. J Am Acad Dermatol 1991; 24: 220-222.
12. King RA, Creel D, Cervenka J et al. Albinism in Nigeria with delineation of a new recessive oculocutaneous type. Clin Genet 1980; 17: 259-270.
13. Bar G. Albinism in Malawi. Malawi Med J 1993; 9: 10-12.
14. Witkop CJ Jr. Albinism. Clin Dermatol 1989; 7: 80-91.
15. Ihn H, Nakamura K, Abe M et al. Amelanotic metastatic melanoma in a patient with oculocutaneous albinism. J Am Acad Dermatol 1993; 28: 895-900.
16. Yakubu A, Mabogunje OA. Skin cancer in African albinos. Acta Oncol 1993; 32: 621-622.
17. Lookingbill DP, Lookingbill GL, Leppard B. Actinic damage and skin cancer in albinos in northern Tanzania: findings in 164 patients enrolled in an outreach skin care program. J Am Acad Dermatol 1995; 32: 653-658.
18. Okoro AN. Albinism in Nigeria. A clinical and social study. Br J Dermatol 1975; 92: 485-492.
19. Dourmishev A. Disorders of the skin pigmentation. Sofia: Medicina i Fizkultura Publishing House, 1986: 49-55.
20. Levine N. Pigmentary abnormalities. In Schachner LA, Hansen RC, eds. Pediatric Dermatology. New York: Churchill Livingstone, 1988: 554-558.
21. Lynch HT, Fusaro RM. Cutaneous signs of cancer-associated genodermatoses. In Lynch HT, Fusaro RM, eds. Cancer-Associated Genodermatoses. New York: Van. Nostrand Reinhold, 1982: 113-115, 519.
22. Spritz RA. Molecular genetics of oculocutaneous albinism. Semin Dermatol 1993; 12: 167-172.
23. Oetting WS, King RA. Molecular basis of oculocutaneous albinism. J Invest Dermatol 1994; 103 (5 Suppl.): 131S-136S.
24. King RA, Summers CG. Albinism. Dermatol Clin 1988; 6: 217-227.
25. Orlow SJ. Congenital disorders of hypopigmentation. Semin Dermatol 1995; 14: 27-32.
26. Shimizu H, Niizeki H, Suzumori K et al. Prenatal diagnosis of oculocutaneous albinism by analysis of the fetal tyrosinase gene. J Invest Dermatol 1994; 103: 104-106.
27. Cameron D. On being an albino: a personal account. Br Med J 1979; 1: 28-29.
28. Ezeilo BN. Psychological aspects of albinism: an exploratory study with Nigerian (Igbo) albino subjects. Soc Sci Med 1989; 29: 1129-1131.
29. Kromberg J. Albinism in the South African negro: IV. attitudes and the death myth. Birth Defects Orig Artic Ser 1992; 28: 159-166.
30. Pearson K, Nettleship E, Usher CH. Monograph on Albinism in Man. Draper's Company Research Memoirs Biometric Series 6, 8, 9. London: Dulay, 1911-1913.
31. Witkop CJ Jr. Albinism. In Harris H, Hirschhorn K, eds. Advances in Human Genetics, Vol. 2. New York: Plenum, 1971: 61-142.
32. Tomita Y. The molecular genetics of albinism and piebaldism. Arch Dermatol 1994; 130: 355-358.
33. Kaposi M. Pathology and treatment of diseases of the skin for practitioners and students. Translation of the last German edition under the supervision of James C. Johnston. New York: William Wood & Co, 1895, 479-480.
34. Oetting WS, King RA. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene. Hum Mutat 1993; 2: 1-6.
35. Ramsay M, Colman M, Stevens G et al. The tyrosinase-positive oculocutaneous albinism locus maps to chromosome 15q11.2-q12. Am J Hum Genet 1992; 51: 879-884.
36. Rinchik EM, Bultman SJ, Horsthemke B et al. A gene for the mouse pink-eyes dilution locus and for human type II oculocutaneous albinism. Nature 1993; 361: 72-76.
37. Puri N, Gardner JM, Brilliant MH. Aberrant PH of melanosomes in pink-eyed dilution (p) mutant melanocytes. J Invest Dermatol 2000; 115: 607-613.
38. Matsunaga J, Dakeishi-Hara M, Tanita M et al. A splicing mutation of the tyrosinase gene causes yellow oculocutaneous albinism in a Japanese patient with a pigmented phenotype. Dermatology 1999; 199: 124-129.
39. Biswas S, Lloyd IC. Oculocutaneous albinism. Arch Dis Child 1999; 80: 565-569.
40. King RA, Lewis RA, Townsend D et al. Brown oculocutaneous albinism: clinical, ophthalmological, and biochemical characterization. Ophthalmology 1985; 92: 1046-1505.
41. Carden SM, Boissy RE, Schoettker PJ, Good WV. Albinism: modern molecular diagnosis. Br J Ophthalmol 1998; 82: 189-195.
42. Kromberg JG, Castle DJ, Zwane EM et al. Red or rufous albinism in southern Africa. Ophthalmic Pediatr Genet 1990; 11: 229-235.
43. Manga P, Kromberg JG, Box NF et al. Rufous oculocutaneous albinism in southern African blacks is caused by mutations in the TYRP1 gene. Am J Hum Genet 1997; 61: 1095-1101.
44. Walsh RJ. A distinctive pigment of the skin in New Guinea indigenes. Ann Hum Genet 1971; 34: 379-388.
45. Dephino RA, Kaplan KL. The Hermansky-Pudlak Syndrome. Report of three cases and review of pathophysiology and management considerations. Medicine 1985; 64: 192-202.
46. Hermansky PF, Pudlak P. Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: report of two cases with histochemical studies. Blood 1959; 14: 162.
47. Witkop CJ, Nunez Babcock M, Rao GH et al. Albinism and Hermansky-Pudlak in Puerto Rico. Bol Asoc Med P R 1990; 82: 333-339.
48. Schinella RA, Greco MA, Cobert BL et al. Hermansky-Pudlak syndrome with granulomatous colitis. Ann Intern Med 1980; 92: 20-23.
49. Davies BH, Tuddenham EGD. Familial pulmonary fibrosis associated with oculocutaneous albinism and platelet function defect. A new syndrome. Q J Med 1976; 45: 219-232.
50. Schallreuter KU, Beazley WD, Hibberts NA et al. Perturbed epidermal pterin metabolism in Hermansky-Pudlak syndrome. J Invest Dermatol 1998; 111: 511-516.
51. Barak Y, Nir E. Chédiak-Higashi syndrome. Am J Pediatr Hematol Oncol 1987; 9: 42-55.
52. McFadden AW. Skin disease in the Cuña Indians. Arch Dermatol 1961; 84: 1013-1023.
53. Kromberg JG, Castle D, Zwane EM, Jenkins T. Albinism and skin cancer in Southern Africa. Clin Genet 1989; 36: 43-52.
54. Luande J, Henschke CI, Mohammed N. The Tanzanian human albino skin: natural history. Cancer 1985; 55: 1823-1828.
55. Stoll DB, Ruschak P, Kauh Y et al. Lentigo maligna in a woman with oculocutaneous albinism. Arch Dermatol 1981; 117: 360-361.
56. Wood C, Graham D, Willsen J, Strefling A. Albinism in amelanotic melanoma. Arch Dermatol 1982; 118: 283-284.
57. Pehamberger H, Honigsmann H, Wolff K. Dysplastic nevus syndrome with multiple primary amelanotic melanomas in oculocutaneous albinism. J Am Acad Dermatol 1984; 11: 731-735.
58. Levine EA, Ronan SG, Shirali SS, Das Gupta TK. Malignant melanoma in a child with oculocutaneous albinism. J Surg Oncol 1992; 51: 138-142.
59. Eady RA, Gunner DB, Garner A, Rodeck CH. Prenatal diagnosis of oculocutaneous albinism by electron microscopy of fetal skin. J Invest Dermatol 1983; 80: 210-212.
60. Levy ML, Magee W. Postnatal testing for unusual genodermatoses. Dermatol Clin 1994; 12: 93-97.
61. Matsunaga J, Dakeishi-Hara M, Miyamura Y et al. Sequence-based diagnosis of tyrosinase-related oculocutaneous albinism: successful sequence analysis of the tyrosinase gene from blood spots dried on filter paper. Dermatology 1998; 196: 189-193.
62. Lever WF, Schaumburg-Lever G. Histopathology of the Skin, 7th edn. Philadelphia: JB Lippincott, 1990: 489.
63. Kugelman TP, Van Scott EJ. Tyrosine activity in melanocytes of human albinos. J Invest Dermatol 1961; 37: 73-76.
64. Tsuji T, Saito T. Multiple naevocellular naevi in brothers with albinism. Br J Dermatol 1978; 98: 685-692.
65. Broodbakker JTW, Westerhof W, Van Dorp DB. Ultrastructure of the skin of human albinos. Ophthal Paed Gen 1983; 2: 95-107.
66. Fonda G. Characteristics and low-vision correction in albinos. Arch Ophthalmol 1962; 68: 754.
67. Taylor WO. The albino fellowship. Int J Dermatol 1982; 21: 84-85.
68. Wilson R. Support group for persons with albinism. Dermatol Nurs 1992; 4: 484.